News

CTC investigators awarded new funding

10/01/19

We are very pleased to announce recent results from NHMRC awards to Investigators at the CTC. Congratulations to Ann Livingstone and Xanthi Coskinas on each being awarded an NHMRC PHD Scholarship. Rachael Morton, Lisa Askie and Mbathio Dieng were each successful in being awarded NHMRC Project Grants. We were also successful in being part of a new NHMRC CRE  grant in translational breast cancer research. 

CTC Chief Investigator

Scheme

Title

Grant award

Ann Livingstone

NHMRC Postgraduate Scholarship

The costs, benefits and patient and clinician preferences of adjuvant immunotherapy in melanoma (Health Economics)

$84,106

 

Xanthi Coskinas

NHMRC Postgraduate Scholarship

Changes to design aspects of ongoing randomised controlled trials (RCT)

$64,057

A/Prof Rachael Morton (CIA)

NHMRC Project Grant

Can symptom monitoring with feedback to clinicians improve the lives of people on dialysis? (SWIFT)

$1,732,011

Prof Lisa Askie (CIA)

NHMRC Project Grant

Cord Clamping and Placental Transfusion at Preterm Birth: an individual participant data and network meta-analysis

$354,872

Dr Mbathio Dieng (CIH)

NHMRC Project Grant

Can patient-led surveillance detect recurrent or new primary melanoma & reduce need for routinely scheduled follow-up? A Randomised Controlled Trial.

$1,229,190

Prof John Simes (CII)

NHMRC Centres of Research Excellence

Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic

$2,496,428

A/Prof Anand Hardikar (CIA)

Danish Diabetes Academy Visiting Professorship

Assessing and Simulating (Pre-)miRNA Expression (ASPiRE) Study

$79,000

A/Prof Mustafa Khasraw (CIA)

Cure Brain Cancer Grant

Sequitur: SEQUential Immunotherapy in Underserved Rare cancers

$500,000

A/Prof Mustafa Khasraw (CIE)

ARC Grant

Precision and the person. A sociological study of innovation in cancer care

$470,000

Prof Kei Lui

MRFF – Rare Diseases

Does withholding enteral feeds around blood transfusion reduce the incidence of NEC in very preterm infants. The international WHEAT study.

$1,606,000

Dr Craig Gedye

COGNO

MRFF – Brain Cancer

MAGMA – Multi-Arm Glioblastoma Australasia Trial

$2,422,000

Dr Hao-Wen Sim COGNO

MRFF – Brain Cancer

PICCOG – PARP and Immune Checkpoint Inhibitor Combination for relapsed IDH-mutant high grade glioma

$1,391,000